Research Article
Establishment of a Monoclonal Antibody-Based Enzyme-Linked Immunosorbent Assay to Measure Soluble B7-H5 in Patients with Cancer
Table 2
The relationship between the levels of sB7-H5 in sera of patients with CRC and clinicopathological characteristics.
| | Characteristics | | sB7-H5 expression | | | | | Median (Min–Max) | ~ | | |
| | Age | | | | | | | ≤65 | 37 | 382.1 (157.4-715.0) | 275.8-479.3 | 580.0 | 0.2614 | | >65 | 37 | 396.7 (168.2-1185) | 311.4-510.0 | | | | Gender | | | | | | | Male | 48 | 358.4 (169.4-1184) | 288.1-497.8 | 614.0 | 0.9127 | | Female | 26 | 406.7 (157.4-1185) | 295.7-496.8 | | | | TNM | | | | | | | I+II | 17 | 283.6 (159.8-607.4) | 240.9-387.4 | 264.0 | 0.0040 | | III+IV | 57 | 412.6 (157.4-1185) | 322.5-510.0 | | | | Metastasis | | | | | | | No | 14 | 282.4 (159.8-607.4) | 218.1-401.6 | 236.0 | 0.0101 | | Yes | 60 | 405.6 (157.4-1185) | 321.5-504.4 | | |
|
|
TNM: tumor node metastasis. ; . |
